ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Jagsonpal Pharmaceuticals (JAGSNPHARM.NSE)
Jagsonpal Pharmaceuticals share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹223.06▲ +5.34%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Jagsonpal Pharmaceuticals in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Jagsonpal Pharmaceuticals
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Jagsonpal Pharmaceuticals a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹209.98 and ₹237.24; in 9 out of 10, between ₹188.45 and ₹264.35. Estimated annual volatility is 30%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹14.4B
- Market cap (USD)
- $152M
- P/E ratio
- 32.5
- Dividend yield
- 7.34%
- 52-week high
- ₹264.50
- 52-week low
- ₹155.00
- Revenue (12 months)
- ₹2.9B
- Operating margin
- 18.4%
- Net margin
- 15.5%
- Beta
- -0.27
What this means
ATLAS does not publish a fair value for JAGSNPHARM.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks JAGSNPHARM.NSE has traded between ₹155.00 and ₹264.50. Today it is 15.7% below that high and 44% above its low.
On the business: net margin is 15.5%; it trades at 32.5 times earnings.
Its beta is -0.27: it tends to move less than the market.
About the company
Jagsonpal Pharmaceuticals Ltd. is a prominent player in the pharmaceutical industry, known for its development, production, and distribution of specialty and generic pharmaceutical drugs.
Want to see everything about Jagsonpal Pharmaceuticals?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Jagsonpal Pharmaceuticals do?
Jagsonpal Pharmaceuticals Ltd. is a prominent player in the pharmaceutical industry, known for its development, production, and distribution of specialty and generic pharmaceutical drugs.
What is the chance JAGSNPHARM.NSE goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, JAGSNPHARM.NSE ends the month between ₹209.98 and ₹237.24.
How big is Jagsonpal Pharmaceuticals and what is its P/E ratio?
Jagsonpal Pharmaceuticals's market capitalization is ₹14.4B. Its price-to-earnings (P/E) ratio is 32.5: you pay ₹32.5 for each ₹1.00 of yearly earnings.
Does Jagsonpal Pharmaceuticals pay a dividend?
Yes. JAGSNPHARM.NSE's current dividend yield is 7.34% at today's price (₹223.06).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer